Life expectancy for pancreatic cancer really hasn’t changed in the last 40 years or so, and only about 5% survive 5 years.
In this study of pancreatic ductal adenocarcinoma it was shown that adding CBD from cannabis (marijuana) to the treatment regimen in these mice nearly tripled the survival time.
The authors recommend that clinical trials should be performed with the promise of substantial improvement in patient outcomes.
